14.2 BYDUREON BCISE Glycemic Control Trials in Adults with Type 2 Diabetes Mellitus BYDUREON BCISE versus BYETTA, Both as Monotherapy or as Add-on to Metformin, a Sulfonylurea, a Thiazolidinedione, or Combination of Oral Agents A 28-week, randomized, open-label comparator-controlled trial was conducted to compare the safety and efficacy of BYDUREON BCISE to BYETTA in adult patients with type 2 diabetes and inadequate glycemic control with diet and exercise alone or with oral antidiabetic therapy, including metformin, a sulfonylurea, a thiazolidinedione, or a combination of any two of these therapies (Trial 1 - NCT01652716)
For more, check out our full report on Ro (dataset)
The Anesthesia Association came out with some new guidelines of what to do to prepare before surgery if you are are on a GLP-1 Agonist (semaglutide, ozempic, wegovy, mounjaro)
Benefits and Risks Explained GHK-Cu creams: Benefits, uses, and buying tips GHK-Cu is often formulated into creams or serums that target visible signs of aging